ROLE OF IMMUNOHISTOCHEMICAL EXPRESSION OF D2-40 MARKER IN HIGH-GRADE DYSPLASIA, MICROINVASIVE AND FRANKLY INVASIVE ORAL SQUAMOUS CELL CARCINOMA

Authors

  • Syeda Areeba Rehan Department of Oral Pathology, Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi-Pakistan
  • Wajeeha Rashid Department of Oral Pathology, Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi-Pakistan
  • Manahil Rahat Department of Oral Pathology, Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi-Pakistan

DOI:

https://doi.org/10.55519/JAMC-03-12983

Keywords:

D2-40 monoclonal antibody, Dysplasia, Oral Squamous Cell Carcinoma, Podoplanin

Abstract

Background: Oral squamous cell carcinoma (OSCC) is a prevalent malignancy that develops through a series of stages, ranging from high-grade dysplasia (HGD), microinvasive OSCC (MiOSCC) to frankly invasive OSCC. However, sometimes it is difficult to differentiate HGD from MiOSCC and invasive OSCC in histopathological morphology on routine staining. The aim of the study was to assess the expression patterns of D2-40 in these distinct stages of oral carcinogenesis, providing insights into its potential role as a biomarker for disease progression. Methods: This cross-sectional study was carried out in the Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from 1st Dec 2023 to 5th Feb 2024. It involved the application of a D2-40 immunohistochemical marker on a total of thirty tissue samples, ten patients diagnosed with High-grade dysplasia (HGD), ten with Microinvasive Oral squamous cell carcinoma (OSCC), and ten invasive OSCC cases. SPSS was used for data analysis and a p-value < 0.05 was considered significant. Results: The mean age of patients was 60.47±11.78 years, males were affected more (70%). D2-40 was expressed in different stages of oral carcinogenesis in increasing order as in 40% in HGD (4/10), and 90% in both microinvasive (9/10) and invasive OSCC (9/10) lesions. D2-40 IHC expression was associated with the patient's age and disease. Conclusion: Podoplanin (D2-40) has the potential to be a novel biomarker for the timely identification of microinvasion in early oral epithelial pathologies with diagnostic dilemmas.

References

Rai P, Ng A, Intekhab I, Sim YF, Lai CW, Loh JP. Oral Cancer in Asia - a systematic review. Ann Oral Maxillofac Surg 2022;8:100366.

Saldivia-Siracusa C, Araújo AL, Arboleda LP, Abrantes T, Ramos MB, Mendonça N, et al. Insights into incipient oral squamous cell carcinoma: A comprehensive South-American study. Med Oral Patol Oral Cir Bucal 2024;29(4):e575–83.

Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis 2021;27(8):1862–80.

González-Ruiz I, Ramos-García P, Ruiz-Ávila I, González-Moles MÁ. Early diagnosis of oral cancer: A complex polyhedral problem with a difficult solution. Cancers 2023;15(13):3270.

Srinivasan V, Kumar GK, Shyam ND, Narayen V, Konda P, Rani KS. Microinvasive Oral Squamous Cell Carcinoma Redefined by Using Modified Cajal Trichrome Differential Stain− A Histochemical Study. J Orofacial Sci 2022;14(1):71–9.

Sridharan G, Sheeba A, Bhandare P. Microinvasive oral squamous cell carcinoma-A clinicopathological study. Med Res Arch 2017;5(7):1–11.

Bhatla N, Aoki D, Nand D, Rengaswamy S. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet 2021;155:28–44.

Essat M, Cooper K, Bessey A, Clowes M, Chilcott JB, Hunter KD. Diagnostic accuracy of conventional oral examination for detecting oral cavity cancer and potentially malignant disorders in patients with clinically evident oral lesions: Systematic review and meta‐analysis. Head Neck 2022;44(4):998–1013.

Bernard C, Zhang JZ, Klieb H, Blanas N, Xu W, Magalhaes M. Clinical outcomes of oral epithelial dysplasia managed by observation versus excision. Head Neck 2023;45(12):3096–106.

Tilakaratne WM, Jayasooriya PR, Jayasuriya NS, De Silva RK. Oral epithelial dysplasia: Causes, quantification, prognosis, and management challenges. Periodontol 2000 2019;80(1):126–47.

Sharma G, Kumar R, Singh HP, Gupta M, Gupta M. Expression of podoplanin in tumor cells and lymphatic vessels in both tumoral and peritumoral areas and correlation with metastatic potential of oral squamous cell carcinoma. J Oral Maxillofac Pathol 2021;25(1):131–5.

Kalele K, Bhondekar V, Dongare S, Khan W, Shelotkar A, Badukale K, et al. Morphology of cells undergoing epithelial mesenchymal transition in micro-invasive and early-invasive oral squamous cell carcinoma–a light microscopic study. Pol J Pathol 2023;73(3):244–54.

Saldivia-Siracusa C, Araújo AL, González-Arriagada WA, Nava FJ, Hunter KD, Lopes MA, et al. Histopathological parameters reported in micro-invasive oral squamous cell carcinoma: a systematic review. Med Oral Patol Oral Cir Bucal 2023;136(1):e55.

Qiao X, Sun Y, Zou Y, Lin J, Xu W, Zong Y, et al. Immunohistochemical staining of podoplanin is helpful in determining the microinvasion of cervical squamous cell carcinoma. Ann Diagn Pathol 2020;46:151493.

Poomsawat S, Kariya A, Nimmanon T, Kosanwat T, Juengsomjit R, Sirima SA. Diagnostic potential of Type VII Collagen during oral carcinogenesis. J Appl Oral Sci 2023;31:e20220486.

Berndt A, Gaßler N, Franz M. Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin γ2 Chain in Tumor Biology, Diagnosis, and Therapy. Cancers (Basel) 2022;14(19):4903.

Ibrahim AM, Alqalshy E, Abdel-Hafiz AA, Abd El-Rahman K, Alazzazi M, Omar MR. Immunohistochemical Evaluation of CD31 and D2-40, Expression in Oral Squamous Cell Carcinoma. Preprints 2022;2022:030006.

Pătru A, Şurlin V, Mărgăritescu C, Ciucă EM, Matei M, Dumitrescu D, et al. Immunohistochemical evaluation of D2-40, Galectin-3, Maspin and MCM7 expression in palate squamous cell carcinomas. Rom J Morphol Embryol 2021;62(1):133–49.

Aiswarya A, Suresh R, Janardhanan M, Savithri V, Aravind T, Mathew L. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation. J Oral Maxillofac Pathol 2019;23(1):159.

Chutipongpisit K, Parachuru VP, Friedlander LT, Hussaini HM, Rich AM. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer. Int J Exp Pathol 2021;102(6):268–78.

Mourad EA. Stromal Cell Diversity in Tumor Microenvironment Promote Invasion of Oral Squamous Cell Carcinoma. Egypt Dent J 2023;69(3):1877–86.

Saito H, Oikawa M, Kouketsu A, Takahashi T, Kumamoto H. Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions. Odontology 2020;108(2):166–73.

Khan SJ, Gawande M, Hande A, Patil S, Sonone A. Immunoexpression of Podoplanin in Leukoplakia and Oral Squamous Cell Carcinoma and its Correlation with Survival: A Research Protocol. J Clin Diagn Res 2022;16(12):1–3.

Downloads

Published

2024-09-08